USE OF COVERED CHEATHAM-PLATINUM STENT IN THE TREATMENT FOR COARCTATION OF THE AORTA

Authors

  • Dr. Syed Asif Akbar Shah Armed Forces Institute of Cardiology (AFIC)/National Institute of Heart Diseases (NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Dr. Khurram Akhtar Armed Forces Institute of Cardiology (AFIC)/National Institute of Heart Diseases (NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Dr. Nadeem Sadiq Armed Forces Institute of Cardiology (AFIC)/National Institute of Heart Diseases (NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Dr. Mehboob Sultan Armed Forces Institute of Cardiology (AFIC)/National Institute of Heart Diseases (NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Dr. Amjad Mahmood Armed Forces Institute of Cardiology (AFIC)/National Institute of Heart Diseases (NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Dr. Aziz Ahmed Armed Forces Institute of Cardiology (AFIC)/National Institute of Heart Diseases (NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Dr. Abdul Salam Wazir Armed Forces Institute of Cardiology (AFIC)/National Institute of Heart Diseases (NIHD)/National University of Medical Sciences (NUMS) Rawalpindi Pakistan

Keywords:

Covered cheatham platinum stent, Re-coarctation, Coarctation

Abstract

Objective: To share our institutional experience of cCP stent (Covered Cheatham-Platinum stent) implantation in children and adults with native and Re-COA (Coarctation of Aorta).

Study Design: A retrospective cross sectional study.

Place and Duration of Study: This study was conducted at Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD) Rawalpindi Pakistan, from Jan 2016 to Oct 2018.

Materials and Methods: Retrospective analysis of all consecutive patients who underwent cCP stent implantation for COA was carried out to assess its immediate, short and intermediate term efficacy and safety.

Results: A total of 25 individuals diagnosed with significant COA (native and re COA) with a median age of 18years were enrolled. About 15 were male (M: F, 1.5: 1). 23 pt’s had native coarctation and 2 had re coarctation. Mean follow up duration was 14.8 months (range 1 to 29 months). Immediate success was achieved in 100% by significant reduction of pre vs post stenting mean peak systolic pressure gradient (68 mmHg vs 12 mmHg, p<0.001) and increase in the mean minimum aortic diameter (3.5 mm vs 12.8 mm, p<0.001). Mean systolic and diastolic BP was significantly reduced after the procedure in 18 (72%). Complications occurred in 18 (72%), which included transient pulse loss in 16 (64%) and restenosis in 2 (8%).

Conclusion: Percutaneous CP stent implantation is a very effective and safe intervention for both native and re coarctation in reducing the coarctation gradient and increasing the lesion diameter.

Downloads

Download data is not yet available.

Downloads

Published

09-05-2019

Issue

Section

Original Articles

How to Cite

1.
Shah DSAA, Akhtar DK, Sadiq DN, Sultan DM, Mahmood DA, Ahmed DA, et al. USE OF COVERED CHEATHAM-PLATINUM STENT IN THE TREATMENT FOR COARCTATION OF THE AORTA. Pak Armed Forces Med J [Internet]. 2019 May 9 [cited 2024 Dec. 25];69(Suppl 1):S42-7. Available from: https://pafmj.org/PAFMJ/article/view/2817